Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL.

Por Ramachandra, S, Metcalf, R A, Fredrickson, T, Marti, G E, Raveche, E
Publicado em 1996

Induction of autoimmunity in normal mice by thymectomy and administration of polyclonal B cell activators: association with contrasuppressor function.

Por Smith, H R, Green, D R, Smathers, P A, Gershon, R K, Raveche, E S, Steinberg, A D
Publicado em 1983

Therapeutic Implications of Activation of the Host Gene (Dleu2) Promoter for miR-15a/16-1 in Chronic Lymphocytic Leukemia (CLL)

Por Kasar, S, Underbayev, C, Yuan, Y, Hanlon, M, Aly, S, Chang, V, Batish, M, Gavrilova, T, Badiane, F, Degheidy, H, Marti, G, Raveche, E
Publicado no Oncogene (2013)